Patents by Inventor Junghyeon Hong

Junghyeon Hong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-HER2/anti-4-1BB bispecific antibody and use thereof
    Patent number: 12240913
    Abstract: Provided are an anti-4-1BB/anti-HER2 bispecific antibody, and a pharmaceutical composition and a method for treating and/or preventing a cancer using the same.
    Type: Grant
    Filed: July 27, 2020
    Date of Patent: March 4, 2025
    Assignees: ABL BIO INC., YUHAN CORPORATION
    Inventors: Hyejin Chung, Yeryoung Yong, Kyeongsu Park, Eunyoung Park, Ui-Jung Jung, Yangsoon Lee, Eunjung Kim, Yong-Gyu Son, Wonjun Son, Seawon Ahn, Donghoon Yeom, Chanmoo Lee, Junghyeon Hong, Moo Young Song, Eun-Jung Lee, Na Rae Lee, Young Bong Park, Eun-Jung Lee, Taewang Kim
  • Method for Purifying Biologically Active Peptide by Using Protein A Affinity Chromatography
    Publication number: 20230212217
    Abstract: Provided is a method of purifying a mixture of Fc-containing bioactive peptides by using an affinity column including an affinity matrix containing a protein A ligand, wherein the mixture of Fc-containing bioactive peptides includes a first Fc-containing bioactive peptide and a second Fc-containing bioactive peptide, and the second Fc-containing bioactive peptide includes at least one more human VH3 domain, compared to the first Fc-containing bioactive peptide. According to the purification method, bioactive peptides having the same or similar structures can be precisely separated to the high level of purity while simplification of the process is achieved.
    Type: Application
    Filed: December 24, 2020
    Publication date: July 6, 2023
    Applicant: ABL BIO INC.
    Inventors: Daehae Song, Youngdon Pak, Jinwon Jung, Junghyeon Hong, Heejin Lim, Dongin Kim
  • ANTI-HER2/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF
    Publication number: 20210024650
    Abstract: Provided are an anti-4-1BB/anti-HER2 bispecific antibody, and a pharmaceutical composition and a method for treating and/or preventing a cancer using the same.
    Type: Application
    Filed: July 27, 2020
    Publication date: January 28, 2021
    Inventors: Hyejin CHUNG, Yeryoung Yong, Kyeongsu Park, Eunyoung Park, Ui-Jung Jung, Yangsoon Lee, Eunjung Kim, Yong-Gyu Son, Wonjun Son, Seawon Ahn, Donghoon Yeom, Chanmoo Lee, Junghyeon Hong, Moo Young Song, Eun-Jung Lee, Na Rae Lee, Young Bong Park, Eun-Jung Lee, Taewang Kim